Covered recipient · General Payments record
LOGAN JAY SHOCKLEY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$3,014.34
- Reported across 130 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,231.98 | 56 |
| Education | $41.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $208.99 | 8 |
| Daiichi Sankyo Inc. | $140.00 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $120.78 | 6 |
| Genentech USA, Inc. | $112.97 | 6 |
| Regeneron Healthcare Solutions, Inc. | $104.84 | 2 |
| Acerta Pharma LLC | $85.12 | 5 |
| Celgene Corporation | $73.68 | 4 |
| SANOFI-AVENTIS U.S. LLC | $41.99 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $36.31 | 2 |
| Incyte Corporation | $35.67 | 2 |
| ABBVIE INC. | $34.10 | 1 |
| PFIZER INC. | $33.54 | 2 |
| JAZZ PHARMACEUTICALS INC. | $25.31 | 1 |
| Exelixis Inc. | $23.61 | 1 |
| Stemline Therapeutics Inc. | $20.83 | 1 |
| Merck Sharp & Dohme Corporation | $18.38 | 1 |
| Dendreon Pharmaceuticals LLC | $17.91 | 1 |
| ADC Therapeutics America, Inc. | $17.20 | 1 |
| Lilly USA, LLC | $16.66 | 1 |
| Ipsen Biopharmaceuticals, Inc | $16.25 | 1 |
| TAIHO ONCOLOGY, INC. | $15.93 | 1 |
| EISAI INC. | $15.77 | 1 |
| ARRAY BIOPHARMA INC | $15.69 | 1 |
| Karyopharm Therapeutics Inc. | $14.72 | 1 |
| Rigel Pharmaceuticals, Inc. | $14.64 | 1 |
| Pharmacosmos Therapeutics Inc. | $13.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (57)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.